{"id":"W2004516600","doi":"10.1038/bjc.2014.164","title":"Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital","funders":"Ministry of Science and Technology of the People's Republic of China; Leukemia and Lymphoma Society","keywords":"Downregulation and upregulation; Apoptosis; Puma; Cancer research; Multiple myeloma; In vivo; Gene knockdown; Unfolded protein response; XBP1; Bortezomib; Endoplasmic reticulum; Dexamethasone; Doxorubicin; Biology; Medicine; Immunology; Chemotherapy; Internal medicine; Cell biology; RNA splicing; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002457268,0.0001439103,0.0002702363,0.00007403614,0.00003852593,0.00006507829,0.0001329126,0.00008737771,0.000008048191],"category_scores_gemma":[0.00008873258,0.0001502969,0.00004187022,0.00009580421,0.0001123279,0.00001607467,0.00007092125,0.0002015616,1.152422e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002399657,"about_ca_system_score_gemma":0.0001165931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001766181,"about_ca_topic_score_gemma":0.0006506488,"domain_scores_codex":[0.9989979,0.0001182126,0.0002408612,0.0002547502,0.0001643778,0.0002239463],"domain_scores_gemma":[0.9994657,0.00001754386,0.0001990801,0.0001002953,0.00008544786,0.0001319208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003383652,0.0001225771,0.0434833,0.00006397151,0.00004024568,0.0001714424,0.00003303831,0.00008961416,0.88964,6.489385e-7,0.0001092943,0.06590755],"study_design_scores_gemma":[0.001672637,0.0001189122,0.3037347,0.0004777024,0.00002480753,0.0002593446,0.00001713334,0.00005253703,0.6925075,0.00001165145,0.0009354446,0.0001876348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856244,0.01395882,0.00006600648,0.00005765403,0.0001277531,0.00009371185,0.00003054069,0.000002729078,0.00003841953],"genre_scores_gemma":[0.9965574,0.003013987,0.0001462586,0.00008865564,0.0001509817,0.000008909768,0.00000250867,0.00002065105,0.00001066549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2602514,"threshold_uncertainty_score":0.612893,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01353256638653497,"score_gpt":0.2594923539217653,"score_spread":0.2459597875352304,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}